PharmaCare US announced three executive leadership appointments. Javier Aste will serve as president of the Americas and Jeff Dotzler will serve as vice president of sales for North America. Art Rowe-Cerveny, founding member of the company’s U.S. division, will now lead as executive vice president of marketing for the Americas.
PharmaCare US said Aste brings a wealth of experience from his senior roles around the globe, most recently at Coty and Procter & Gamble. He prides himself on being a results-oriented senior leader, with a core focus on growing market share, sales and profit. He will be ushering in the next chapter of growth and innovation, the company said.
“Retailers and consumers are pushing for purposeful innovation,” Aste said. “Our core brand, Sambucol, is primed for its next phase of growth. Product innovation will be central to our next chapter.”
Aste succeeds Brad Olsen, who served as the Americas leader from 2013 before his retirement in April 2022.
Dotzler joined the PharmaCare team on May 1, 2022, bringing his years of leadership experience from IRI, Crossmark and, most recently, Coty’s beauty division. “He will finesse and bolster the PharmaCare go-to-market strategy to deliver new competitive advantages for the company,” PharmaCare said.
“PharmaCare is at an exciting stage in its history. I’m eager to create new sales opportunities to boost the company’s already impressive growth trajectory,” Dotzler said.
Lannett to be exclusive distributor of generic Fludara
Lannett has entered into an agreement with Areva Pharmaceuticals to be the exclusive U.S. distributor of fludarabine phosphate for injection 50 mg/2 ml, single-dose vials.
The medication is the generic of Bayer AG's Fludara.
"Fludarabine phosphate for injection represents a continuation of our push to new dosage forms with attractive market opportunities," said Lannett CEO Tim Crew.
"Moreover, a drug market shortage has recently existed for fludarabine phosphate for injection, so our goal, subject to FDA clearance, is to commence marketing as soon as possible, targeting later this calendar year, to help patients gain access to this important oncology medicine," Crew said. "We are pleased to establish a new strategic relationship with Areva Pharmaceuticals and look forward to launching this product."
Fludarabine phosphate for injection had a market value of roughly $4.9 million for the 12 months ending March 2022, according to IQVIA. However, the current market value is believed to be higher due to recent market disruptions.
Under the agreement, Lannett will provide sales, marketing and distribution support for the medication, for which it will receive a share of the profits. Other financial terms were not disclosed.
There’s a new addition to the Rice Krispies Treats family.
The Battle Creek, Mich.-based company released Homestyle Cinnamon Sugar variety, which features fluffy marshmallows, golden butter and a sprinkle of warm cinnamon.
“Whether you’re a busy parent packing lunchboxes or a grown-up kid craving a taste of childhood, fans can enjoy this deliciously sticky, simple snack any time of day and be transported to a homey kitchen in just one bite,” said Heidi Ray, senior director of brand marketing at Kellogg’s portable wholesome snacks. “What’s more, this is the first-ever Cinnamon Sugar flavor for our Rice Krispies Treats brand, and we’re excited to add it to our beloved line of Homestyle bars.”
Rice Krispies Treats Homestyle Cinnamon Sugar is now available at grocery stores nationwide in a pack of six that retails for $3.99 and a pack of 12 for $5.24.
Loblaw has completed the previously announced acquisition of Lifemark Health Group from Audax Private Equity.
Lifemark is a leading provider of outpatient physiotherapy, massage therapy, occupational therapy, chiropractic mental health and other ancillary rehabilitation services in Canada. With this acquisition, Loblaw through its wholly owned subsidiary Shoppers Drug Mart, adds to its growing role as a healthcare service provider, with a network of health-and-wellness solutions accessible in person and digitally.
Loblaw is Canada's food and pharmacy leader, with a network of more than 2,400 corporate, franchised and associate-owned locations in communities across the country. Loblaw's purpose — Live Life Well — supports the needs and well-being of Canadians who make 1 billion visits each year to the company's stores.
Led by Shoppers Drug Mart, the leader in Canada's retail drug store marketplace and the No. 1 provider of pharmacy products and services, Loblaw offers full-service pharmacies and a range of services like prescriptions, med checks, vaccinations, minor-ailment diagnoses and nutrition consultations in more than 1,800 locations in 10 provinces and 2 territories, including in Shoppers Drug Mart, PharmaPrix, Loblaw pharmacy, DRUGStore Pharmacy and CENTRESante locations.
Lifemark Health Group is a Canadian leader in community rehabilitation, workplace health and wellness and medical assessment services. With over 20 years of service excellence, Lifemark Health Group, a comprehensive and trusted health provider with 3 million patient visits annually, employs over 5,000 highly trained clinicians, medical experts and team members, the company said.
As Canada's largest physiotherapy company, Lifemark said that it is passionate about enriching the health of Canadians through movement.